SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 413 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $326,688 | +45.8% | 2,695 | +55.9% | 0.31% | +201.0% |
| Q4 2022 | $224,044 | -48.7% | 1,729 | -70.3% | 0.10% | -49.0% |
| Q2 2022 | $437,000 | -51.4% | 5,826 | -41.6% | 0.20% | -56.0% |
| Q4 2021 | $899,000 | +162.9% | 9,981 | +367.7% | 0.46% | +99.6% |
| Q2 2020 | $342,000 | +1.5% | 2,134 | -18.4% | 0.23% | +31.8% |
| Q4 2019 | $337,000 | +81.2% | 2,614 | +5.7% | 0.17% | +183.6% |
| Q3 2019 | $186,000 | – | 2,473 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |